url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
url url
A deadly synthetic drug up to 500 times more potent than heroin has arrived in Western Australia, leaving some users in hospital intensive care.
As the Sunday Times can reveal, there have been at least three cases of overdoses of deadly synthetic opioid drugs called Nitazene in WA in the past 18 months – some of them requiring intensive care treatment.
Subscribers with digital access can view this article.
Are you already a subscriber?